Abstract
Gene editing is increasing its popularity day by day especially as an essential tool for the research. It is based on two recombination mechanisms in mammalian cells: nonhomologous end-joining (NHEJ) and homology-directed repair (HDR). The first one can be used to silence a specific gene or a portion of it and the second one to insert new DNA, in presence of a donor template, in a targeted position in the genome. In order to exploit one of these two mechanisms, three major targeted nucleases have been developed: zinc-finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and CRISPR-Cas (clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein). The last one seems to be the most promising tool among the others for gene editing. By using the properties and versatility of the Cell Penetrating Peptide (CPP) PepFect14, we developed a protocol to deliver a plasmid encoding for CRISPR-Cas9 and Green Fluorescent Protein (GFP) in BHM cell line expressing luciferase (Bomirsky Hamster Melanoma pLuc). Aiming to knocking down the luciferase gene in the cell line and to expressing GFP. Having two fast and easy read-outs of the plasmid’s activity at the same time. Furthermore, by labeling the CRISPR plasmid with Cy5 it is possible to have a visual confirmation of the cellular uptake of the pDNA/CPP complex, via fluorescent microscopy, as described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Porteus MH, Carroll D (2005) Gene targeting using zinc finger nucleases. Nat Biotechnol 23:967–973
Christian M, Cermak T, Doyle EL et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757–761
Ru R, Yao Y, Yu S et al (2013) Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs. Cell Regen 2:5
Liu J, Gaj T, Patterson JT et al (2014) Cell-penetrating peptide-mediated delivery of talen proteins via bioconjugation for genome engineering. PLoS One 9:e85755
Liu J, Gaj T, Wallen MC et al (2015) Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids 4:e232
Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821
Shalaby K, Aouida M, El-Agnaf O (2020) Tissue-specific delivery of CRISPR therapeutics: strategies and mechanisms of non-viral vectors. Int J Mol Sci 21:E7353
Ramakrishna S, Dad A-BK, Beloor J et al (2014) Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res 24:1020–1027
Ha JS, Byun J, Ahn D-R (2016) Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption. Sci Reports 6:22847
Lostalé-Seijo I, Louzao I, Juanes M et al (2017) Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition. Chem Sci 8:7923–7931
Del’Guidice T, Lepetit-Stoffaes J-P, Bordeleau L-J et al (2018) Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells. PLoS One 13:e0195558
Chung JY, Ain QU, Song Y et al (2019) Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance. Genome Res 29:1442–1452
He X-Y, Liu B-Y, Peng Y et al (2019) Multifunctional vector for delivery of genome editing plasmid targeting β-catenin to remodulate cancer cell properties. ACS Appl Mater Interfaces 11:226–237
Krishnamurthy S, Wohlford-Lenane C, Kandimalla S et al (2019) Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nat Commun 10:4906
Helmfors H, Eriksson J, Langel Ü (2015) Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides. Anal Biochem 484:136–142
Acknowledgments
This work was supported by the Swedish Research Council.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Falato, L., Vunk, B., Langel, Ü. (2022). CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14. In: Langel, Ü. (eds) Cell Penetrating Peptides. Methods in Molecular Biology, vol 2383. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1752-6_38
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1752-6_38
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1751-9
Online ISBN: 978-1-0716-1752-6
eBook Packages: Springer Protocols